Interleukin-6 Involvement in Antidepressant Action of Hypericum Perforatum

Hypericum, a plant widely used as antidepressant has been shown to interact with the immune system. We studied the effects of the administration of the Hypericum perforatum extract Ph-50, a Hypericum extract, standardized to flavonoids (50 %) and containing 0.3 % of hypericin and 4.5 % of hyperforin in a forced swimming test and tryptophan, serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) diencephalic content using a high performance liquid chromatography method in male interleukin-6 (IL-6) knock-out (IL-6^-/-) and wild type (IL-6^+/+) mice. Hypericum extract (Ph-50; 500 mg/kg) oral acute administration reduced the immobility time of wild type, but not of knockout mice. Tryptophan content was not modified by Hypericum in all the animal groups. Serotonin and 5-HIAA diencephalic content was increased by Hypericum in both wild type and knockout mice. However, the increase observed in the wild type was greater than in knockout mice. These data indicate that IL-6 could be necessary to the antidepressant action of Hypericum, and that this cytokine (probably) mediates the effects of Hypericum through activation of the serotonin system.

References

• 1 Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine.  Adv Immunol. 1993;  54 1-78
• 2 Barkhudaryan N, Dunn A J. Molecular mechanisms of actions of interleukin-6 on the brain, with special reference to serotonin and the hypothalamo-pituitary-adrenocortical axis.  Neurochem Res. 1999;  24 1169-1180
• 3 Barton B E. The biological effects of interleukin-6.  Med Res Rev. 1996;  16 87-109
• 4 Baumann H, Gauldi J. The acute phase response.  Immunol Today. 1994;  15 74-80
• 5 Bladt S, Wagner H. Inhibition of MAO by fractions and constituents of Hypericum extract.  J Geriatric Psychiatr Neurol. 1994;  7 S57-S59
• 6 Bennett D A, Phun L, Polk J F, Voglino S A, Zlotnik V, Raffa R B. Neuropharmacology of St. John's Wort (Hypericum).  Ann Pharmacother. 1998;  32 1201-1208
• 7 Calapai G, Crupi A, Firenzuoli F, Inferrera G, Campo G M, Caputi A P. Effects of Hypericum perforatum on levels of 5-Hydroxytryptamine, Noradrenaline and Dopamine in the cortex, diencephalon and brainstem of the rat.  J Pharm Pharmacol. 1999a;  51 723-728
• 8 Calapai G, Corica F, Corsonello A, Sautebin L, Di Rosa M, Campo G M, Buemi M, Nicita Mauro V, Caputi A P. Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis.  J Clin Invest. 1999b;  104 975-982
• 9 Kluger M J, Kozak W, Leon L R, Conn C A. The use of knockout mice to understand the role of cytokines in fever.  Clin Exp Pharmacol Physiol. 1998;  25 141-144
• 10 Linde K, Ramirez G, Mulrow C D, Pauls A, Weidenhammer W, Melchart D. St John's wort for depression - an overview and meta-analysis of randomised clinical trials.  Brit Med J. 1996;  313 253-258
• 11 Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs.  Behav Pharmacol. 1997;  8 523-532
• 12 Lutgendorf S K, Garand L, Buckwalter K C, Reimer T T, Hong S Y, Lubaroff D M. Life stress, mood disturbance, and elevated interleukin-6 in healthy older women.  J Gerontol A Biol Sci Med Sci. 1999;  54 M434-M439
• 13 Meyers C A. Mood and cognitive disorders in cancer patients receiving cytokine therapy.   Adv Exp Med Biol. 1999;  461 75-81
• 14 Müller W E, Rossol R. Effects of Hypericum extract on the expression of serotonin receptors.  J Geriatr Psychiatry Neurol. 1994;  7 (Suppl. 1) S63-S64
• 15 Müller W E, Singer A, Wonnemann M, Hafner U, Rolli M, Schafer C. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract.  Pharmacopsychiat.. 1998;  31 (Suppl. 1) 16-2 1
• 16 Nahrstedt A, Butterweck V. Biologically active and other chemical constituents of the herb of Hypericurn perforatum L.  Pharmacopsychiat.. 1997;  30 (Suppl. 2) 29-34
• 17 Nathan P. The experimental and clinical pharmacology of St. John's Wort (Hypericum perforatum L).  Mol. Psichiatry. 1999;  4 333-338
• 18 Porsolt R D, Anton G, Blavet N, Jafre M. Behavioral despair in rats: A new model sensitive to antidepressant.  Eur J Pharmacol. 1978;  47 379-391
• 19 Schobitz B, de Kloet E R, Holsboer F. Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain.  Prog Neurobiol. 1994;  44 397-432
• 20 Schobitz B, de Kloet E R, Sutanto W, Holsboer F. Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain.  Eur J Neurosci. 1993;  5 1426-1435
• 21 Schobitz B, Pezeshki G, Pohl T, Hemman U, Heinrich P C, Holsboer F, Reul J MHM. Soluble interleukin-6 (IL-6) receptor augments central effects of IL-6 in vivo.  FASEB J. 1995;  9 659-664
• 22 Sébire G, Emilie D, Wallon C, Wry C, Devergne O, Delfraissy J F, Galanaud P, Tardieu M. In vitro production of IL-6, IL-1b, and tumor necrosis factor-a by human embryonic microglial and neural cells.  J Immunol. 1993;  150 1517-1523
• 23 Seidel A, Rothermundt M, Rink L. Cytokine production in depressed patients.  Adv Exp Med Biol. 1999;  461 47-57
• 24 Song C, Merali Z, Anisman H. Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment.  Neuroscience. 1999;  88 823-836
• 25 Suzuki O, Katsumata Y, Oya M, Bladt S, Wagner H. Inhibition of monoamine oxidase by hypericin.  Planta Med.. 1984;  50 272-274
• 26 Thiele B, Brink I, Ploch, M. Modulation of cytokine expression by hypericum extract.  J Geriatr Psychiatry Neurol. 1994;  7 (Suppl. 1) S60-S62
• 27 Yu P H. Effect of Hypericum perforatum extract on serotonin turnover in the mouse brain.  Pharmacopsychiat.. 2000;  33 60-65
• 28 Wang J, Dunn A J. Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism.  Neurochem Int. 1998;  33 143-154